Collaborative Network

REPLICor has established collaborations with numerous institutions worldwide to bring on board world class expertise in the testing and development of REP 9AC.  These institutions include:

• Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

• Baylor College of Medicine (Houston, Texas)

• CHUQ, Laval University (Quebec, Quebec)

• Centre National de Référence des Virus Influenza (Lyon, France)

• Cincinnati Children’s Hospital (Cincinnati, Ohio)

• Department of Medical Biophysics, University of Toronto (Toronto, Ontario)

• Fourth Military Medical University (People’s Republic of China)

• Hepatitis Viral Research Group, University of Adelaide (Adelaide, Australia)

• International Center for Genetic Engineering and Biotechnology ICGEB (New Delhi, India)

• Mt. Sinai School of Medicine (New York, New York)

• National Microbiology Laboratory (Winnipeg, Manitoba)

• National Scientific Research Institut INRS-IAF (Laval, Québec)

• New York Blood Center (New York, New York)

• NIH / NDDK Liver Disease Institute (Bethesda, Maryland)

• NIH / NIAID Antiviral testing program (Bethesda, Maryland)

• Rocky Mountain Labs, NIH (Hamilton, Montana)

• Southern Research Institute (Birmingham, Alabama)

• Tropical Medicine Institute of Guangzhou, University of Traditional Chinese Medicine, China

• University of Texas Medical Branch (Galveston, Texas)